|
Volumn 323, Issue 7306, 2001, Pages
|
Long term anticoagulation or antiplatelet treatment. Giving warfarin always depends on balancing risks.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
WARFARIN;
BLEEDING;
CEREBROVASCULAR ACCIDENT;
CHEMICALLY INDUCED DISORDER;
DRUG ADMINISTRATION;
HUMAN;
NOTE;
RISK ASSESSMENT;
ANTICOAGULANTS;
ASPIRIN;
CEREBROVASCULAR ACCIDENT;
DRUG ADMINISTRATION SCHEDULE;
HEMORRHAGE;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
RISK ASSESSMENT;
WARFARIN;
|
EID: 17344394227
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (2)
|
References (0)
|